PSS26 - COST EFFECTIVENESS OF OCRIPLASMIN FOR TREATMENT OF SYMPTOMATIC VITREOMACULAR ADHESION IN THE UNITED STATES
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2526
https://www.valueinhealthjournal.com/article/S1098-3015(18)35828-5/fulltext
Title :
PSS26 - COST EFFECTIVENESS OF OCRIPLASMIN FOR TREATMENT OF SYMPTOMATIC VITREOMACULAR ADHESION IN THE UNITED STATES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35828-5&doi=10.1016/j.jval.2018.09.2526
First page :
Section Title :
Open access? :
No
Section Order :
1878